Intelligent Bio Solutions Secures U.S. Patent for Drug Screening

Intelligent Bio Solutions ( (INBS) ) has shared an update.

On March 26, 2025, Intelligent Bio Solutions Inc. announced the granting of a U.S. patent for its Intelligent Fingerprinting Drug Screening Cartridge, marking its sixth active U.S. patent. This patent strengthens the company’s intellectual property portfolio and competitive position as it plans to enter the multi-billion dollar U.S. market in 2025. The patent covers the lateral flow test strip technology used in the company’s drug screening system, which detects drugs in fingerprint sweat. This development is part of INBS’s strategy to leverage the expanding global drug screening market, with a recent FDA 510(k) submission and plans for U.S. market entry.

More about Intelligent Bio Solutions

Intelligent Bio Solutions Inc. (NASDAQ: INBS) is a medical technology company specializing in intelligent, rapid, non-invasive testing solutions. The company focuses on its Intelligent Fingerprinting Drug Screening System, which utilizes fingerprint sweat analysis to detect drugs commonly found in workplaces. This technology is designed to be hygienic, cost-effective, and provides results in under ten minutes, catering to industries such as construction, manufacturing, transport, and drug treatment organizations.

YTD Price Performance: 24.82%

Average Trading Volume: 211,585

Technical Sentiment Signal: Buy

Current Market Cap: $14.31M

See more data about INBS stock on TipRanks’ Stock Analysis page.